annual meeting program - American Society of Clinical Oncology

More documents

Recommendations

Info

Monday, June 7, 2010 Brd. 10C A phase I study evaluating the pharmacokinetics (PK) and pharmacodynamics (PD) of the oral pan-phosphoinositide-3 kinase (PI3K) inhibitor GDC-0941. (Abstract #2613) R. D. Baird, R. S. Kristeleit, D. Sarker, D. Olmos, S. K. Sandhu, Y. Yan, H. Koeppen, G. G. Levy, J. Jin, J. S. De Bono 307 MONDAY
MONDAY Monday, June 7, 2010 8:00 AM - 12:00 PM GENERAL POSTER SESSION Developmental Therapeutics—Experimental Therapeutics Location: S Hall A2 Tracks(s): Developmental Therapeutics Brd. 10D Phase I study of PF-03446962, a fully human mab against ALK 1, a TGF� receptor involved in tumor angiogenesis. (Abstract #3034) L. W. Goff, F. G. De Braud, R. B. Cohen, J. Berlin, C. Noberasco, H. Borghaei, E. Wang, D. Hu Lowe, W. J. Levin, C. Gallo-Stampino Brd. 10E Phase I dose-escalation study of continuously administered regorafenib (BAY 73-4506), an inhibitor of oncogenic and angiogenic kinases, in patients with advanced solid tumors. (Abstract #3035) T. Shimizu, A. W. Tolcher, A. Patnaik, K. Papadopoulos, O. Christensen, T. Lin, G. R. Blumenschein Jr. Brd. 10F French, multicentric, prospective study of dynamic contrast-enhanced ultrasound (DCE-US) for the evaluation of antiangiogenic treatments in 400 patients. (Abstract #3036) N. Lassau, J. Lacroix, S. Taieb, R. Aziza, V. Vilgrain, M. Cuinet, A. Sarran, C. Labbe, A. Jean-Pierre, S. Koscielny Brd. 10G Placental growth factor as a marker of therapeutic response to treatment with motesanib in patients with progressive advanced thyroid cancer, advanced nonsquamous non-small cell lung cancer, and locally recurrent or advanced metastatic breast cancer. (Abstract #3037^) M. B. Bass, M. T. Davis, L. Kivman, H. Khoo, K. Notari, G. R. Blumenschein Jr., J. R. Mackey, S. I. Sherman, Y. Hei, S. D. Patterson Brd. 10H Final results from a phase I study of TRC093 (humanized anti-cleaved collagen antibody) in patients with solid cancer. (Abstract #3038) F. Robert, M. S. Gordon, L. S. Rosen, D. S. Mendelson, M. Mulay, B. J. Adams, D. Alvarez, C. P. Theuer, B. R. Leigh Brd. 11A Analysis of early hypertension (HTN) and clinical outcome with bevacizumab (BV). (Abstract #3039) H. Hurwitz, P. S. Douglas, J. P. Middleton, G. W. Sledge, D. H. Johnson, D. A. Reardon, D. Chen, O. Rosen Brd. 11B Treatment of VHL patients with sunitinib: Clinical outcomes and translational studies. (Abstract #3040) S. F. Matin, I. E. McCutcheon, D. S. Gombos, S. Waguespack, N. M. Tannir, S. Wen, D. W. Davis, L. A. Smith, G. Fuller, E. Jonasch Brd. 11F Phase Ib study of PTC299, a novel oral inhibitor of tumor VEGF expression, in patients with advanced cancer. (Abstract #3041) G. K. Schwartz, M. A. Dickson, L. A. Callahan, C. H. Darby, M. Llorente, Y. Cao, H. J. Dials, L. L. Miller, H. H. Miao Brd. 11G Interim safety and pharmacodynamic results for ALN-VSP02, a novel RNAi therapeutic for solid tumors with liver involvement. (Abstract #3042) J. Gollob, J. R. Infante, G. Shapiro, P. LoRusso, B. J. Dezube, J. Heymach, J. Cehelsky, R. Falzone, A. Vaishnaw, H. A. Burris III Brd. 11H Phase I study of sorafenib (S) with bevacizumab (B) and paclitaxel (P) in patients (pts) with refractory solid tumors. (Abstract #3043) E. G. Chiorean, D. Matei, A. Younger, J. M. Funke, M. J. Waddell, D. R. Jones, N. M. Hahn, S. M. Perkins, K. Sandrasegaran, C. Sweeney Brd. 12A Proposal of a new population pharmacokinetics (PK) model of sorafenib and rationale for a three-daily schedule. (Abstract #3044) P. Boudou-Rouquette, B. Blanchet, O. Mir, B. Billemont, S. Ropert, S. Barete, R. Coriat, N. Franck, M. Tod, F. Goldwasser 308
Page 1 and 2:
46th Annual Meeting June 4-8, 2010
Page 3 and 4:
SESSIONS AND SYMPOSIA SCIENTIFIC SE
Page 5 and 6:
SESSIONS AND SYMPOSIA continued SPE
Page 7 and 8:
ANNUAL MEETING PLANNING COMMITTEES
Page 9 and 10:
ANNUAL MEETING PLANNING COMMITTEES
Page 11 and 12:
CONTINUING MEDICAL EDUCATION INFORM
Page 13 and 14:
ONSITE DETAILS continued floor plan
Page 15 and 16:
ASCO SHUTTLE SERVICE Complimentary
Page 17 and 18:
POLICIES Important Security and Att
Page 19 and 20:
AWARDS continued 2010 Merit Awards
Page 21 and 22:
AWARDS continued 2010 Advanced Clin
Page 23 and 24:
AWARDS continued 2010 International
Page 25 and 26:
AWARDS continued 2006 YIA Paul Halu
Page 27 and 28:
2010 ANNUAL MEETING SUPPORTERS* THE
Page 29 and 30:
2010 ANNUAL MEETING SUPPORTERS cont
Page 31 and 32:
PROGRAM BY TRACK Breast Cancer cont
Page 33 and 34:
PROGRAM BY TRACK Central Nervous Sy
Page 35 and 36:
PROGRAM BY TRACK Developmental Ther
Page 37 and 38:
PROGRAM BY TRACK Gastrointestinal (
Page 39 and 40:
PROGRAM BY TRACK Genitourinary Canc
Page 41 and 42:
PROGRAM BY TRACK Gynecologic Cancer
Page 43 and 44:
PROGRAM BY TRACK International cont
Page 45 and 46:
PROGRAM BY TRACK Lymphoma and Plasm
Page 47 and 48:
PROGRAM BY TRACK Patient and Surviv
Page 49 and 50:
PROGRAM BY TRACK Pediatric Oncology
Page 51 and 52:
PROGRAM BY TRACK Professional Devel
Page 53 and 54:
PROGRAM BY TRACK Special Sessions c
Page 55 and 56:
FRIDAY Friday, June 4, 2010 1:00 PM
Page 57 and 58:
Page 59 and 60:
FRIDAY Friday, June 4, 2010 Sex and
Page 61 and 62:
Page 63 and 64:
FRIDAY Friday, June 4, 2010 Brd. 7
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
SATURDAY Saturday, June 5, 2010 7:3
Page 81 and 82:
SATURDAY Saturday, June 5, 2010 Mel
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
SATURDAY Saturday, June 5, 2010 Brd
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
SATURDAY Saturday, June 5, 2010 Dis
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
SATURDAY Saturday, June 5, 2010 Imp
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
SUNDAY Sunday, June 6, 2010 7:30 AM
Page 191 and 192:
Page 193 and 194:
SUNDAY Sunday, June 6, 2010 PARP In
Page 195 and 196:
Page 197 and 198:
SUNDAY Sunday, June 6, 2010 Brd. 2D
Page 199 and 200:
SUNDAY Sunday, June 6, 2010 Brd. 5F
Page 201 and 202:
Page 203 and 204:
SUNDAY Sunday, June 6, 2010 Brd. 13
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
SUNDAY Sunday, June 6, 2010 Discuss
Page 231 and 232:
SUNDAY Sunday, June 6, 2010 Discuss
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
SUNDAY Sunday, June 6, 2010 10:30 A
Page 243 and 244:
SUNDAY Sunday, June 6, 2010 11:30 A
Page 245 and 246:
SUNDAY Sunday, June 6, 2010 1:00 PM
Page 247 and 248:
Page 249 and 250:
SUNDAY Sunday, June 6, 2010 2:00 PM
Page 251 and 252:
Page 253 and 254:
Page 255 and 256: SUNDAY Sunday, June 6, 2010 2:00 PM
Page 257 and 258: SUNDAY Sunday, June 6, 2010 Brd. 3G
Page 259 and 260: SUNDAY Sunday, June 6, 2010 Brd. 6F
Page 261 and 262: SUNDAY Sunday, June 6, 2010 Brd. 9G
Page 263 and 264: SUNDAY Sunday, June 6, 2010 Brd. 14
Page 289 and 290: SUNDAY Sunday, June 6, 2010 The Evo
Page 291 and 292: MONDAY Monday, June 7, 2010 7:30 AM
Page 295 and 296: MONDAY Monday, June 7, 2010 The Bio
Page 299 and 300: MONDAY Monday, June 7, 2010 Brd. 7
Page 301 and 302: MONDAY Monday, June 7, 2010 Brd. 2D
Page 303 and 304: MONDAY Monday, June 7, 2010 Brd. 5E
Page 305: MONDAY Monday, June 7, 2010 Brd. 8F
Page 313 and 314: MONDAY Monday, June 7, 2010 TRIALS
Page 315 and 316: MONDAY Monday, June 7, 2010 Breast
Page 317 and 318: MONDAY Monday, June 7, 2010 Central
Page 345 and 346: MONDAY Monday, June 7, 2010 11:45 A
Page 357 and 358:
MONDAY Monday, June 7, 2010 Discuss
Page 359 and 360:
MONDAY Monday, June 7, 2010 Brd. 2F
Page 361 and 362:
MONDAY Monday, June 7, 2010 Brd. 5G
Page 363 and 364:
MONDAY Monday, June 7, 2010 Brd. 9A
Page 365 and 366:
MONDAY Monday, June 7, 2010 Brd. 13
Page 367 and 368:
Page 369 and 370:
Page 371 and 372:
Page 373 and 374:
Page 375 and 376:
Page 377 and 378:
MONDAY Monday, June 7, 2010 1:00 PM
Page 379 and 380:
Page 381 and 382:
Page 383 and 384:
Page 385 and 386:
Page 387 and 388:
Page 389 and 390:
MONDAY Monday, June 7, 2010 NCI Com
Page 391 and 392:
Page 393 and 394:
Page 395 and 396:
Page 397 and 398:
Page 399 and 400:
Page 401 and 402:
Page 403 and 404:
Page 405 and 406:
Page 407 and 408:
Page 409 and 410:
Page 411 and 412:
Page 413 and 414:
Page 415 and 416:
TUESDAY Tuesday, June 8, 2010 7:30
Page 417 and 418:
TUESDAY Tuesday, June 8, 2010 Early
Page 419 and 420:
Page 421 and 422:
TUESDAY Tuesday, June 8, 2010 Brd.
Page 423 and 424:
Page 425 and 426:
Page 427 and 428:
Page 429 and 430:
Page 431 and 432:
Page 433 and 434:
Page 435 and 436:
Page 437 and 438:
Page 439 and 440:
Page 441 and 442:
show all

annual meeting program - American Society of Clinical Oncology

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?